Skip to content

Chemed CHE AFS Securities

AFS Securities at other companies

GHC
Graham HoldingsGHC
$256.06M+10.4%

Other financials

Income statement

See full
Revenue$657.5M+1.6%
Gross profit$215.8M-0.3%
Operating income$84.6M-10.7%
Net income$66.3M-7.6%
EPS (diluted)$4.84-0.4%

Balance sheet

See full
Cash & equivalents$16.9M-90.3%
Total debt$236.9M+63.3%
Total equity$848.0M-28.2%
Total assets$1.5B-11.0%

Cash flow

See full
Operating cash flow$88.2M+169%
CapEx$17.1M+28.9%
Free cash flow$71.1M+265%

Valuation

See full
Market cap$5.79B-42.3%
Enterprise value$6.01B-39.6%
P/E22.3×-10.2×
P/S2.3×-1.8×

Profitability

See full
Gross margin32.4%-2.4pp
Operating margin12.9%-2.7pp
Net margin10.2%-2.2pp
FCF margin14.8%+2.2pp

Returns & leverage

See full
Return on equity25.6%-0.5pp
Debt / equity0.3×+0.2×
Current ratio0.9×-0.9×

Where this comes from

Reported directly by Chemed in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxLiabilitiesInvestments.

The official record: Chemed’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Chemed's afs securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Chemed's AFS securities?
Chemed (CHE) reported AFS securities of $3.9M in Q4 2025.
How has Chemed's AFS securities changed year-over-year?
Chemed's AFS securities increased by 6.6% year-over-year, from $3.66M to $3.9M.
What is the long-term trend for Chemed's AFS securities?
Over 5 years (2020 to 2025), Chemed's AFS securities has grown at a 10.4% compound annual growth rate (CAGR), from $2.38M to $3.9M.
What does AFS securities mean?
Debt securities classified as available-for-sale, measured at fair value with unrealized gains/losses in OCI rather than the income statement.